Anondita Medicare
August 22, 2025 – August 26, 2025
| Price | ₹137 - ₹145 |
| Premium | ₹0 |
|---|---|
| Lot size | 1000 |
| Allotment | Aug 28, 2025 |
| Listing | Sep 1, 2025 |
Anondita Medicare About
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| INDIVIDUAL | 2 | 2000 | 290000 | 792 |
| sHNI | 3 | 3000 | 435000 | 76 |
| bHNI | 7 | 7000 | 1015000 | 151 |
IPO Reservation
| Investor Category | Shares Offered | No. of Shares |
|---|---|---|
| Individual | 33.05% | 1584000 |
| BHNI | 9.47% | 454000 |
| SHNI | 4.74% | 227000 |
| Anchor | 28.21% | 1352000 |
| QIB | 18.90% | 906000 |
| Market Maker | 5.63% | 270000 |
| Total | 100.00% | 4793000 |
Anondita Medicare IPO Details
| Total Issue Size | 47,93,000 shares (aggregating up to 69.50 Cr) |
| Fresh Issue | 47,93,000 shares (aggregating up to 69.50 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,32,93,618 shares |
| Share Holding Post Issue | 1,80,86,618 shares |
| Reserved for Market Maker | 2,70,000 shares |
| Market Maker | Mansi Share & Stock Broking Pvt.Ltd. |
Key Performance Indicator
| KPI | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| ROE | 41.71% | 36.31% | 3.99% |
| RONW | 41.71% | 36.31% | 3.99% |
| EPS (basic) | 14.04 | - | - |
| P/E Pre IPO | 11.74 | ||
| P/E Post IPO | 15.98 |
Financial Details In Crores
| Period Ended | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| Assets | 78.27 | 42.92 | 37.8 |
| Total Income | 77.13 | 46.56 | 36.14 |
| Profit After Tax | 16.42 | 3.84 | 0.35 |
| EBITDA | 25.65 | 9.09 | 3.58 |
| Net Worth | 37.87 | 10.59 | 8.69 |
| Reserves and Surplus | 24.58 | 10.39 | 6.55 |
| Total Borrowing | 27.39 | 24.01 | 22.66 |
Company Overview
Founded: March 2024
Core Business: Manufactures flavored male condoms under the brand "COBRA".
Production Capacity: 56.2 crore condoms annually (562 million).
Headquarters & Facility: Noida, Uttar Pradesh, India.
Employees: 295 (as of November 2024).
Market Reach
Exports: Southeast Asia, Africa, and the Middle East.
Distribution: Strong network via wholesalers, retailers, e-commerce, and government health programs.
Partnerships: Collaborates with global NGOs, health organizations, and governments for family planning initiatives.
IPO Objectives (Fund Utilization)
The company aims to raise funds for:
Capital Expenditure: ₹6 crores for machinery/equipment.
Working Capital: ₹35 crores to support operations.
General Corporate Purposes: Unspecified amount for acquisitions/other needs.
Strength
Market Leadership – Strong presence in North India with recognized brand value.
Product Innovation – Wide portfolio including flavored and specialty condoms.
Robust Distribution – Well-established domestic and international supply chain.
Weakness
Negative Cash Flows – Past and potential future negative cash flows may strain growth and operations.
Customer Concentration – Heavy reliance on top 10 customers increases revenue vulnerability.
Government Tender Dependence – Significant reliance on government contracts exposes the business to regulatory and compliance risks.
Anondita Medicare Lead Manager(s)
Anondita Medicare Address
Flat No.704 Narmada Block,
N6, Sec-D
Pkt-6 Vasant Kunj,
New Delhi, New Delhi, 110070
Phone: 0120-4520300
Email: info@anonditamedicare.com
Website: https://anonditamedicare.com/